ETF Managers Group’s Immunocore IMCR Stock Holding History

ETF Managers Group’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$733K	Buy	+14,822	New	+$833K	0.02%	307
2022 Q4	–	Sell	-12,944	Closed	-$608K	–	602
2022 Q3	$608K	Sell	12,944 -914	-7%	-$43.6K	0.02%	327
2022 Q2	$498K	Buy	13,858 +324	+2%	+$10.5K	0.01%	486
2022 Q1	$402K	Buy	13,534 +49	+0.4%	+$1.24K	0.01%	505
2021 Q4	$460K	Sell	13,485 -2,807	-17%	-$102K	0.01%	527
2021 Q3	$603K	Buy	16,292 +3,130	+24%	+$106K	0.01%	483
2021 Q2	$464K	Sell	13,162 -49	-0.4%	-$1.89K	0.01%	548
2021 Q1	$571K	Buy	+13,211	New	+$588K	0.01%	390

Other funds holding IMCR

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ETF Managers Group's IMCR Position: Q1 2023 in Review

ETF Managers Group opened a new position in Immunocore (IMCR) in Q1 2023: 14,822 shares worth $733K. The stake represents 0.02% of the portfolio and ranks #307 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in IMCR as recently as Q3 2022.

ETF Managers Group first reported a position in IMCR in Q1 2021 and has held it in 8 quarters since. 109 funds tracked by Wall St. Rank hold IMCR as of Q1 2023.

ETF Managers Group held 14,822 shares of Immunocore worth $733K as of Q1 2023.
Immunocore was a new ETF Managers Group position in Q1 2023.
Immunocore made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #307 holding.
ETF Managers Group first reported a position in Immunocore in Q1 2021 and has held it in 8 quarters since.
109 funds tracked by Wall St. Rank held Immunocore as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.